Molecular minimal residual disease negativity and decreased stem cell mobilization potential predict excellent outcome after autologous transplant in NPM1 mutant acute myeloid leukemia

• Alvaro de Santiago de Benito,
• Barbara Jeker,
• Eva Gfeller,
• Naomi Porret,
• Yara Banz,
• Urban Novak,
• Ulrike Bacher,
• Thomas Pabst

Affiliations

Alvaro de Santiago de Benito

Department of Medical Oncology, Inselspital, University Hospital and University of Bern, Bern

Barbara Jeker

Department of Medical Oncology, Inselspital, University Hospital and University of Bern, Bern;Center for Hemato-Oncology, University Cancer Institute; University Hospital and University of Bern, Bern

Eva Gfeller

Department of Hematology and Center of Laboratory Medicine (ZLM), Inselspital; University Hospital and University of Bern, Bern

Naomi Porret

Department of Hematology and Center of Laboratory Medicine (ZLM), Inselspital; University Hospital and University of Bern, Bern

Yara Banz

Institute of Pathology, University of Bern, Bern, Switzerland

Urban Novak

Department of Medical Oncology, Inselspital, University Hospital and University of Bern, Bern;Center for Hemato-Oncology, University Cancer Institute; University Hospital and University of Bern, Bern

Ulrike Bacher

Department of Hematology and Center of Laboratory Medicine (ZLM), Inselspital; University Hospital and University of Bern, Bern

Thomas Pabst

Department of Medical Oncology, Inselspital, University Hospital and University of Bern, Bern;Center for Hemato-Oncology, University Cancer Institute; University Hospital and University of Bern, Bern